Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro

Summary by The Korea Times
Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country und...

1 Articles

The Korea TimesThe Korea Times
Lean Left

Samsung Bioepis launches Ustekinumab biosimilar in Japan with Nipro

Samsung Bioepis announced Wednesday the launch of its Ustekinumab biosimilar in Japan, marking the company’s first product debut in the country und...

·Korea (the Republic of)
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Korea Times broke the news in Korea (the Republic of) on Wednesday, May 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Samsung icon

Samsung

Business icon

Business

Japan icon

Japan

Japan Economy icon

Japan Economy

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal